Sign In
NewsRadar

Mission Therapeutics

The company is developing a platform of technologies for the discovery and development of modulators of enzymes involved in cancer and other diseases.

• Show past press releases
• Edit this company

Contact Information
Address:
 
 

Phone:
Web:
Contact:
 
 
Meditrina (Building 260)
Babraham Research Campus
Cambridge CB22 3AT
United Kingdom
+ 44 (0)1223 497454
http://missiontherapeutics.com
Niall Martin
+ 44 (0)1223 497454

Company Facts
Founded:Dec 2010
Founders:Niall Martin , Steve Jackson, Xavier Jacq, Keith Menear
CEO:Niall Martin
CTO or technical lead:Steve Jackson
CFO or finance director:
Head of Sales:
Head of Marketing:

Stage:
Category:Biotechnology & Healthcare
Sector:Biopharmaceuticals
Employees:
Profitability:
Funding raised:Yes
Funding sought:
Seeking Partnerships:

Non-executive Board Members

Key Customers

Key Business Partners

Key Competitors

Capital Raised
DateSizeInvestors
To view this information you must be signed in and subscribed to the online dataservice, sign in here.

To read more about the Online data service click here

Public Offerings
DateTypeExchange
No public offerings


Data


26,126
Tech investments
From our Online Data Service
16,881
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Sep 13N/AEnergy related
Sep 13€12.6MConsumer electronics
Sep 12€39.0MBiopharmaceuticals
Sep 12€2.3MInternet commerce
Sep 12€2.1MInternet services
Sep 12€4.0MMedical devices
Sep 12€9.0MSoftware development

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


May 28
Identiq
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
Nethone
nethone raised over $1 million from innovation nest

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

Jan 2
Urban Jungle
urban jungle raises 1m in seed funding to build tech-enabled home ...





About usContact usLegal Information
Copyright 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.